This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Related articles in JOP Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

ASCO Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: Guideline Summary

	Context

 
ASCO convened an Expert Panel to conduct a systematic review of the literature available through February 2004 on the use of sentinel lymph node biopsy (SNB) in early-stage breast cancer.

	Recommendations

 
The following recommendations are based on the available evidence and address several questions posed by the Panel.

How Should the Results of SNB Be Utilized in Clinical Practice? Can Full Axillary Lymph Node Dissection Be Avoided in Patients Who Have Negative Findings on SNB?
The Panel supports the use of SNB for staging disease in most women with clinically negative axillary lymph nodes. SNB is a reliable technique in trained hands and has an acceptable false-negative rate in the setting of both mastectomy and breast-conserving surgery. Nevertheless, the Panel concludes that axillary lymph node dissection (ALND) should . . . [Click for More]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related articles in JOP:

Clinical Practice Guidelines in Oncology: Translating Evidence Into Practice (and back)

Antonio C. Wolff and Christopher E. Desch
JOP 2005 1: 160-161. [Extract] [Full Text]